Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.

about

Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.

Item

http://www.wikidata.org/entity/Q41439632

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeted Delivery of Neutraliz ...... ement-Dependent Tissue Damage.

@en

type

Item

label

Targeted Delivery of Neutraliz ...... ement-Dependent Tissue Damage.

@en

prefLabel

Targeted Delivery of Neutraliz ...... ement-Dependent Tissue Damage.

@en

P1476

Targeted Delivery of Neutraliz ...... lement-Dependent Tissue Damage

@en

P2093

Antonio F Di Naro

http://www.w3.org/2001/XMLSchema#string

Daniele Sblattero

http://www.w3.org/2001/XMLSchema#string

Fabio Fischetti

http://www.w3.org/2001/XMLSchema#string

Federico Colombo

http://www.w3.org/2001/XMLSchema#string

Francesco Tedesco

http://www.w3.org/2001/XMLSchema#string

Gabriele Baj

http://www.w3.org/2001/XMLSchema#string

Luca De Maso

http://www.w3.org/2001/XMLSchema#string

Paolo Macor

http://www.w3.org/2001/XMLSchema#string

Stefania Biffi

http://www.w3.org/2001/XMLSchema#string

P2860

Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins

Solution structures and integrin binding activities of an RGD peptide with two isomers

Complement. First of two parts

FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Complement: a key system for immune surveillance and homeostasis

The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies.

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins.

Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

The use of eculizumab in renal transplantation.

P304

1093

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01093

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chiara Garrovo

Paolo Durigutto

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932227

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

5592221

http://www.w3.org/2001/XMLSchema#string